Literature DB >> 19815038

Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane.

Kosuke Shimizu1, Masaaki Osada, Koji Takemoto, Yutaka Yamamoto, Tomohiro Asai, Naoto Oku.   

Abstract

Liposomal amphotericin B (AMPH-B), also known as AmBisome, exhibits a potent antifungal effect through its binding to ergosterol contained within the fungal cell membrane. However, the mechanism responsible for the movement of AmBisome-derived AMPH-B to the fungal cell membrane through the cell wall is not yet clear. Therefore, in the present study we aimed at elucidating this mechanism operating in Saccharomyces cerevisiae. AmBisome showed its antifungal effect against S. cerevisiae at 35 degrees C but not at 4 degrees C, whereas free AMPH-B was effective at both temperatures. A significant difference in the amount of AMPH-B transferred to the fungal cells between incubation at 4 and 35 degrees C was also observed when AmBisome was used. Confocal microscopic study, however, indicated that NBD-labeled AmBisome was localized on the surface of the fungal cells at either temperature. To decrease the affinity of AMPH-B for the liposomal membrane, we entrapped AMPH-B in fluid liposomes containing egg yolk phosphatidylcholine (EPC) instead of hydrogenated soy PC (HSPC). These liposomes showed the antifungal effect even at 4 degrees C. On the contrary, AMPH-B in liposomes containing ergosterol (Erg-AmB) instead of cholesterol showed a significantly weaker antifungal effect at 35 degrees C with reduced transfer of AMPH-B to the fungal cells. These results suggest that not the binding of AmBisome to target cells but the transfer of AMPH-B from liposomal membrane of AmBisome to the cell membrane is critical for the antifungal activity of AmBisome. This transfer is dependent on the temperature, fluidity of the liposomal membrane, and the affinity of AMPH-B for the fungal cell membrane. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815038     DOI: 10.1016/j.jconrel.2009.09.019

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

1.  Local delivery polymer provides sustained antifungal activity of amphotericin B with reduced cytotoxicity.

Authors:  Rebecca M Haley; Sean T Zuckerman; Catherine A Gormley; Julius N Korley; Horst A von Recum
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-21

Review 2.  Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

Authors:  Neil R H Stone; Tihana Bicanic; Rahuman Salim; William Hope
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

3.  The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles.

Authors:  Louise Walker; Jill Adler-Moore; Prashant Sood; Megan D Lenardon; Gillian Milne; Jon Olson; Gerard Jensen; Julie Wolf; Arturo Casadevall; Neil A R Gow
Journal:  mBio       Date:  2018-02-06       Impact factor: 7.867

4.  Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.

Authors:  Danillo F M C Veloso; Naiara I G M Benedetti; Renato I Ávila; Thiago S A Bastos; Thaísa C Silva; Maria R R Silva; Aline C Batista; Marize C Valadares; Eliana M Lima
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.